The Chinese government is increasing its efforts to tackle the country's economic slowdown. However, initial enthusiasm in financial markets has faded. For investors, the situation opens up investment opportunities.
US technology stocks are approaching their July highs. Yield enhancement products with a quanto feature allow investors to benefit from yield opportunities while hedging the currency risk.
Givaudan continues to thrive, benefiting from its strong fine fragrances business. This development is also reflected in the share price of the company. However, not all chemical manufacturers are equally successful, as a look at Sika and Clariant shows.
Expectations are high for the US tech giants' quarterly results. However, the stock market's enthusiasm for artificial intelligence has cooled in recent months.
The Swiss equity market performed quite well in the first three quarters of the year. Now, financial markets are heading for an eventful final quarter.
The slowdown in Chinese demand is weighing on the European car industry. At the same time, established manufacturers are having to fend off growing competition from China. The difficulties are reflected in the performance of European car stocks.
Thematic investment and regional diversification: ZKB launches four tracker certificates on equity indices.
Global dividend payments are expected to reach a record high in 2024. Contributing to this growth are Alphabet and Meta Platforms, which paid dividends in the second quarter for the first time in their history. The ZKB Tracker Certificate on a global dividend basket offers investors easy access to the investment theme.
As investors have been rotating out of technology stocks in recent weeks, previously neglected sectors have caught up. Among the winners are consumer staples stocks.
Since October 2023, Sandoz is trading independently of its former parent company Novartis on the Swiss stock exchange. A year earlier, ABB spun off its turbocharger division Accelleron. Both spin-offs have become stock market darlings. Alcon's start as an independent company has been a little more difficult, but it is showing signs of a turnaround this year.
ZKB Barrier Reverse Convertible on worst of Roche Holding AG/Nestlé AG/Novartis AG/The Swatch Group ... 130398049 / CH1303980499 |
ZKB Barrier Reverse Convertible auf Idorsia AG 130396615 / CH1303966159 |
ZKB Autocallable Barrier Reverse Convertible on worst of The Swatch Group AG/Alcon AG/Sandoz Group A... 132910962 / CH1329109628 |
9.52% p.a. ZKB Autocallable Barrier Reverse Convertible, 04.03.2025 on worst of UHR SE/ALC SE/SDZ SE... 132910828 / CH1329108281 |
11.20% p.a. ZKB Autocallable Reverse Convertible, 12.03.2025 on worst of DBK GY/SAN SQ/ABN NA ABN AM... 132911245 / CH1329112457 |